How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-lymphoma-small-lymphocytic.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant lymphoma - small lymphocytic — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant lymphoma - small lymphocytic (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant lymphoma - small lymphocytic, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Copiktra	DUVELISIB	Secura		Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	2018-01-01
Venclexta	venetoclax	AbbVie	BCL-2 Inhibitor [EPC]	Apoptosis regulator Bcl-2	2014-01-01
Imbruvica	ibrutinib	AbbVie	Kinase Inhibitor [EPC]	Tyrosine-protein kinase Blk	2013-01-01
Imbruvica	Imbruvica	Rabin Medical Center		Nuclear receptor subfamily 4 group A member 3, Platelet glycoprotein VI, Serine/threonine-protein kinase LATS1
Zydelig	Zydelig	University of Maryland, Baltimore		DNA-dependent protein kinase catalytic subunit, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 2 drugs in Malignant lymphoma - small lymphocytic
Rabin Medical Center · 1 drug in Malignant lymphoma - small lymphocytic
Secura · 1 drug in Malignant lymphoma - small lymphocytic
University of Maryland, Baltimore · 1 drug in Malignant lymphoma - small lymphocytic

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant lymphoma - small lymphocytic:

Cite this brief

Drug Landscape (2026). Malignant lymphoma - small lymphocytic — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-lymphoma-small-lymphocytic. Accessed 2026-06-10.

Malignant lymphoma - small lymphocytic full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing